Primary liver tumors

被引:0
作者
Lau, WY [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China
来源
SEMINARS IN SURGICAL ONCOLOGY | 2000年 / 19卷 / 02期
关键词
liver neoplasms; liver/surgery; hepatocellular carcinoma; hepatectomy; liver transplantation; liver cirrhosis; risk factors; age factors; sex factors; mass screening; neoplasm metastasis; hemorrhage; alpha-fetoproteins; laparoscopy; interventional ultrasound; combined antineoplastic agents; combined modality therapy; therapeutic embolization; iodine radioisotopes; yttrium radioisotopes; interferon-alpha; hormonal antineoplastic agents; iodized oil; prognosis; survival rate; treatment outcome;
D O I
10.1002/1098-2388(200009)19:2<135::AID-SSU6>3.0.CO;2-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many improvements have been made in the treatment of primary liver tumors, especially in hepatocellular carcinoma. Partial hepatectomy still remains the mainstay of therapy for resectable tumors, and it offers the potential of a cure. Total hepatectomy and liver transplantation may be applicable in selected patients. Palliative resection and tumor debulking operations are beneficial for some malignant tumors. Local ablative therapy can be tried on patients with small tumors who are not suitable candidates for open resectional surgery because of serious associated medical diseases or because of poor liver function. For patients with advanced malignancy new treatment modalities in the form of hepatic artery transcatheter treatment or systemic therapy are on the horizon. Some of these treatment options show very promising results. Properly conducted randomized studies are required to evaluate these new treatment modalities, as well as those older treatment modalities for which there is insufficient data to determine their actual role in the management of patients with liver cancer. Semin. Surg, Oncol. 19:135-144, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 113 条
[1]  
Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO
[2]  
2-S
[3]   Place of cryosurgery in the treatment of malignant liver tumors [J].
Adam, R ;
Akpinar, E ;
Johann, M ;
Kunstlinger, F ;
Majno, P ;
Bismuth, H .
ANNALS OF SURGERY, 1997, 225 (01) :39-49
[4]  
[Anonymous], 1990, ANN SURG, V211, P277
[5]  
AZOULAY D, 1995, J AM COLL SURGEONS, V181, pA267
[6]  
Barbot DJ, 1997, J SURG ONCOL, V64, P63
[7]  
BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
[8]  
2-J
[9]  
BEASLEY RP, 1984, VIRAL HEPATITIS LIVE, P290
[10]   LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151